Cargando…
Gastric cancer with p53 overexpression has high potential for metastasising to lymph nodes.
Overexpression of the tumour suppressor gene p53 was investigated immunohistochemically in 96 primary gastric carcinomas and 26 corresponding metastatic perigastric lymph nodes. Abnormalities in p53 expression were found in 52 (54%) of the 96 primary carcinomas. Tumours stained positively for p53 fr...
Autores principales: | , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1993
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968266/ https://www.ncbi.nlm.nih.gov/pubmed/8439509 |
_version_ | 1782134702699708416 |
---|---|
author | Kakeji, Y. Korenaga, D. Tsujitani, S. Baba, H. Anai, H. Maehara, Y. Sugimachi, K. |
author_facet | Kakeji, Y. Korenaga, D. Tsujitani, S. Baba, H. Anai, H. Maehara, Y. Sugimachi, K. |
author_sort | Kakeji, Y. |
collection | PubMed |
description | Overexpression of the tumour suppressor gene p53 was investigated immunohistochemically in 96 primary gastric carcinomas and 26 corresponding metastatic perigastric lymph nodes. Abnormalities in p53 expression were found in 52 (54%) of the 96 primary carcinomas. Tumours stained positively for p53 frequently metastasised to lymph nodes (the metastatic rate: 85%) compared to findings in those with negative p53 staining (64%, P < 0.05). Ninety-two percent (24/26) of the malignant cells in the lymph nodes stained positively for p53. When the DNA ploidy pattern of the tumour was determined by flow cytometry, the aneuploid tumours in p53 positive and negative groups accounted for 69% and 45%, respectively (P < 0.05). Proliferative activity of the tumour, as measured by Ki-67 labelling, was significantly higher (30.6 +/- 12.0%) in the p53 positive group than that (25.1 +/- 10.7%) in the p53 negative group (P < 0.05). Thus, gastric cancer with a mutant p53 has high proliferative activity and metastasis to lymph nodes will probably occur. IMAGES: |
format | Text |
id | pubmed-1968266 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1993 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-19682662009-09-10 Gastric cancer with p53 overexpression has high potential for metastasising to lymph nodes. Kakeji, Y. Korenaga, D. Tsujitani, S. Baba, H. Anai, H. Maehara, Y. Sugimachi, K. Br J Cancer Research Article Overexpression of the tumour suppressor gene p53 was investigated immunohistochemically in 96 primary gastric carcinomas and 26 corresponding metastatic perigastric lymph nodes. Abnormalities in p53 expression were found in 52 (54%) of the 96 primary carcinomas. Tumours stained positively for p53 frequently metastasised to lymph nodes (the metastatic rate: 85%) compared to findings in those with negative p53 staining (64%, P < 0.05). Ninety-two percent (24/26) of the malignant cells in the lymph nodes stained positively for p53. When the DNA ploidy pattern of the tumour was determined by flow cytometry, the aneuploid tumours in p53 positive and negative groups accounted for 69% and 45%, respectively (P < 0.05). Proliferative activity of the tumour, as measured by Ki-67 labelling, was significantly higher (30.6 +/- 12.0%) in the p53 positive group than that (25.1 +/- 10.7%) in the p53 negative group (P < 0.05). Thus, gastric cancer with a mutant p53 has high proliferative activity and metastasis to lymph nodes will probably occur. IMAGES: Nature Publishing Group 1993-03 /pmc/articles/PMC1968266/ /pubmed/8439509 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Research Article Kakeji, Y. Korenaga, D. Tsujitani, S. Baba, H. Anai, H. Maehara, Y. Sugimachi, K. Gastric cancer with p53 overexpression has high potential for metastasising to lymph nodes. |
title | Gastric cancer with p53 overexpression has high potential for metastasising to lymph nodes. |
title_full | Gastric cancer with p53 overexpression has high potential for metastasising to lymph nodes. |
title_fullStr | Gastric cancer with p53 overexpression has high potential for metastasising to lymph nodes. |
title_full_unstemmed | Gastric cancer with p53 overexpression has high potential for metastasising to lymph nodes. |
title_short | Gastric cancer with p53 overexpression has high potential for metastasising to lymph nodes. |
title_sort | gastric cancer with p53 overexpression has high potential for metastasising to lymph nodes. |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968266/ https://www.ncbi.nlm.nih.gov/pubmed/8439509 |
work_keys_str_mv | AT kakejiy gastriccancerwithp53overexpressionhashighpotentialformetastasisingtolymphnodes AT korenagad gastriccancerwithp53overexpressionhashighpotentialformetastasisingtolymphnodes AT tsujitanis gastriccancerwithp53overexpressionhashighpotentialformetastasisingtolymphnodes AT babah gastriccancerwithp53overexpressionhashighpotentialformetastasisingtolymphnodes AT anaih gastriccancerwithp53overexpressionhashighpotentialformetastasisingtolymphnodes AT maeharay gastriccancerwithp53overexpressionhashighpotentialformetastasisingtolymphnodes AT sugimachik gastriccancerwithp53overexpressionhashighpotentialformetastasisingtolymphnodes |